The rationale for targeting nectin-4 in pancreatic cancer
Trends in Cancer · 2026-06 · 12 (6) · 481-484
DOI: 10.1016/j.trecan.2026.01.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Cancer, 2026-06. Verfasst von Sarah Cronjaeger und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Natio…. Hauptthemen laut MEDLINE: Nectins, Pancreatic Neoplasms, Cell Adhesion Molecules, Carcinoma, Pancreatic Ductal. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Else Kroner-Fresenius Foundation, Federal Ministry of Education and Research Bonn Office, Jung Foundation for Science and Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; National Center for Tumor Diseases (NCT), Dresden, Germany; German Cancer R…
Förderung
- Else Kroner-Fresenius Foundation
- Federal Ministry of Education and Research Bonn Office
- Jung Foundation for Science and Research
Zitieren
APA
Cronjaeger, S., Seifert, L., & Seifert, A. M. (2026). The rationale for targeting nectin-4 in pancreatic cancer. Trends in Cancer, 12(6), 481-484. https://doi.org/10.1016/j.trecan.2026.01.008
Vancouver
Cronjaeger S, Seifert L, Seifert AM. The rationale for targeting nectin-4 in pancreatic cancer. Trends in Cancer. 2026;12(6):481-484. doi:10.1016/j.trecan.2026.01.008
BibTeX
@article{Cronjaeger2026,
author = {Cronjaeger, Sarah and Seifert, Lena and Seifert, Adrian M},
title = {The rationale for targeting nectin-4 in pancreatic cancer},
journal = {Trends in Cancer},
year = {2026},
volume = {12},
number = {6},
pages = {481--484},
doi = {10.1016/j.trecan.2026.01.008}
}
EUVIMED